Laborie Announces First Procedures in ENDURE 1 Study with the Optilume® Ureteric Drug-Coated Balloon
Laborie Medical Technologies, a global leader in diagnostic and therapeutic devices, today announced the successful completion of the first procedures using the Optilume® Ureteric Drug-Coated Balloon ...
Laborie Medical Technologies Inc. continued a string of recent deals with an agreement to acquire Urotronic Inc. for $255 million cash up front with an additional $345 million in payments contingent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results